SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...

Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, ...

Discover Viatris' Q3 2025 earnings highlights: strengthened financials, raised guidance, pipeline progress, and strategic cost savings.

NEW YORK (PIX11) – A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was distributed nationwide to distributors, the recall stated.

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Axsome incurs wider-than-expected Q3 loss but revenues soar 63% on booming Auvelity sales, with Sunosi and the newest drug, Symbravo, aiding the top line.

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - ...

Viatris, Inc. (($VTRS)) has held its Q3 earnings call. Read on for the main highlights of the call. Viatris, Inc. recently held its earnings call, ...

Your doctor may order a creatinine test to assess the health of your kidneys. A high creatinine level could be a sign of an issue such as chronic kidney disease (CKD). Creatinine is a waste product ...

Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.

Ascendis Pharma A/S v. Biomarin Pharm. Inc., 25-5696 (N.D. Cal.) July 7, 2025 Hon. P. Casey Pitts Voxzogo® (vosoritide powder for injection) RE48,267 Janssen Pharms ...